Elora – Developing a systemically delivered enzyme to remove microplastics from the human body

Elora Therapeutics is developing the first systemically delivered enzyme therapeutic designed to degrade and safely remove microplastics accumulating in the human body. The therapeutic targets three indications linked to plastic exposure: endocrine disruption, metabolic dysfunction, and chronic inflammation.

Their goal is FDA approval of their therapeutic as a novel biologic for treatment of microplastic-associated chronic conditions.